Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 551-560 of 562 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Solitary Bone Plasmacytomas to Elucidate Their Pathogenesis and Risk of Progression to Multiple Myeloma

    Rochester, MN

  2. Changes in GI Inflammation and the GI Microbiome Profile in Women With Breast Cancer Throughout Chemotherapy

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Contrast-enhanced rectal photon-counting detector CT for the local staging of rectal cancer

    Rochester, MN

  4. A Study of the Bacteria Found in Cancerous and Non-cancerous Breast Tissue

    Rochester, MN

  5. TRPC6 to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure (Prospective Study)

    Jacksonville, FL

  6. Screening for High Frequency Malignant Disease

    Rochester, MN, Eau Claire, WI, La Crosse, WI

  7. Cancer Distress Management Program for Liver and Biliary Cancer within a SPORE

    Rochester, MN

  8. A Prospective Ocular Tumor Study

    Rochester, MN

  9. DiviTum Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients

    Jacksonville, FL

  10. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer